ATE542885T1 - Impfungs-ausführungsarten - Google Patents

Impfungs-ausführungsarten

Info

Publication number
ATE542885T1
ATE542885T1 AT99912985T AT99912985T ATE542885T1 AT E542885 T1 ATE542885 T1 AT E542885T1 AT 99912985 T AT99912985 T AT 99912985T AT 99912985 T AT99912985 T AT 99912985T AT E542885 T1 ATE542885 T1 AT E542885T1
Authority
AT
Austria
Prior art keywords
ari
sub
vaccination
necatrix
performance types
Prior art date
Application number
AT99912985T
Other languages
English (en)
Inventor
David Richards
Wayne Jorgensen
Norman Stewart
Original Assignee
Eimeria Pty Ltd
State Of Queensland Through The Dept Of Primary Ind
Rural Ind Res And Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eimeria Pty Ltd, State Of Queensland Through The Dept Of Primary Ind, Rural Ind Res And Dev Corp filed Critical Eimeria Pty Ltd
Application granted granted Critical
Publication of ATE542885T1 publication Critical patent/ATE542885T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99912985T 1998-03-30 1999-03-30 Impfungs-ausführungsarten ATE542885T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2683A AUPP268398A0 (en) 1998-03-30 1998-03-30 Vaccination modalitites
PCT/AU1999/000232 WO1999050387A1 (en) 1998-03-30 1999-03-30 Vaccination modalities

Publications (1)

Publication Number Publication Date
ATE542885T1 true ATE542885T1 (de) 2012-02-15

Family

ID=3806944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912985T ATE542885T1 (de) 1998-03-30 1999-03-30 Impfungs-ausführungsarten

Country Status (7)

Country Link
US (1) US7211265B2 (de)
EP (1) EP1068293B1 (de)
JP (1) JP4549530B2 (de)
AT (1) ATE542885T1 (de)
AU (1) AUPP268398A0 (de)
ES (1) ES2383429T3 (de)
WO (1) WO1999050387A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
MX2010012869A (es) 2008-05-29 2010-12-14 Intervet Int Bv Vacunas contra coccidiosis.
MX2011005133A (es) 2008-11-13 2011-08-04 Intervet Int Bv Vacuna contra eimeria para pavos.
WO2020018325A1 (en) * 2018-07-10 2020-01-23 Applied Lifesciences And Systems Poultry, Inc. Method of preparing and delivering oocyst solutions
JP2025508028A (ja) 2022-03-08 2025-03-21 イプラ、サイエンティフィック、エセ、エレ、ウ コクシジウム症に対する卵内ワクチン組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
ES2054679T3 (es) * 1986-08-18 1994-08-16 British Tech Group Vacunas.
AU5989894A (en) * 1993-01-19 1994-08-15 Merck & Co., Inc. Live coccidiosis vaccine

Also Published As

Publication number Publication date
JP4549530B2 (ja) 2010-09-22
ES2383429T3 (es) 2012-06-21
US7211265B2 (en) 2007-05-01
EP1068293A4 (de) 2004-12-22
EP1068293A1 (de) 2001-01-17
US20050008659A1 (en) 2005-01-13
WO1999050387A1 (en) 1999-10-07
JP2002509941A (ja) 2002-04-02
AUPP268398A0 (en) 1998-04-23
EP1068293B1 (de) 2012-01-25

Similar Documents

Publication Publication Date Title
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
BR9916857A (pt) 4 heteroaril diarilaminas
IT1214567B (it) Struttura di chiodo endomidollare, ed apparecchiatura per il suo inserimento nell'osso.
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
EE200200507A (et) Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine
RU95112465A (ru) Пирановые соединения, фармацевтическая композиция, способ получения и промежуточные соединения
MXPA02007099A (es) Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina.
UA87815C2 (ru) Иммуногенная или вакцинная композиция для защиты от кокцидиоза и способ индуцирования иммунного ответа у цыплят
DE69732709D1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
MA27609A1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
WO2003039592A3 (de) Zelluläre impfstoffe mit adjuvanzien
ATE542885T1 (de) Impfungs-ausführungsarten
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
EP0600396A3 (de) Darmprotozoe Impfstoffe.
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
CA2222482A1 (en) Non-virulent mycoplasma synoviae and vaccine thereof
BR9813634A (pt) "abridores de canal de potássio"
DK1159426T3 (da) Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner
ATE331042T1 (de) Identifizierung von eimeria spezies und stämmen auf pcr-basis
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
BR0011889A (pt) Cepa bacteriana, plasmìdio, processo de preparação de uma cepa bacteriana e de exopolissacarìdeo bacteriano e ácido nucleico
AU2001282277A1 (en) Treatment of mycobacterial infection
TR200002675T2 (tr) Paroksetinin kristalin formu.
UA67251A (en) Strain paramixovirus-3 bovis "zksm" for the preparation of vaccines and diagnosticums